Mixed
Bariatric surgery is the only weight-loss treatment providing sustained weight loss and improvement of obesity-related comorbidities, yet access is inequitably distributed based on sociodemographic factors.
Bariatric surgery is the most effective treatment for morbid obesity, but access is not equal. If you meet the medical criteria (BMI ≥40 or ≥35 with comorbidities), systemic factors like income, race, or location may prevent you from receiving it. The paper calls for identifying these specific barriers to improve equity.
Bariatric surgery is the only weight-loss treatment available that results in both sustained weight loss and improvements of obesity-related comorbidities... However, the population who actually receives bariatric surgery does not reflect the individuals who need it the most.
Why this rating
This is a protocol for a systematic review; it cites existing evidence supporting the efficacy of surgery but does not present new primary data.
Source
Health inequity in access to bariatric surgery: a protocol for a systematic review
Timothy Jackson et al. · Systematic Reviews · 2014
DOI 10.1186/2046-4053-3-15
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →